Literature DB >> 35096474

Elevated Level of CXCL13 in Nonenhancing Diffuse Primary Lymphoma of the Brainstem.

Dietrich Sturm1, Marco Tosch1, Jörg Felsberg1, Cornel Haupt1, Martin Kitzrow1.   

Abstract

Entities:  

Year:  2021        PMID: 35096474      PMCID: PMC8794475     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


× No keyword cloud information.
  8 in total

1.  CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity.

Authors:  K Mark Ansel; Ruth B S Harris; Jason G Cyster
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

2.  Non-enhancing primary CNS lymphoma.

Authors:  M L Lachenmayer; E Blasius; P Niehusmann; A Kovacs; M Stuplich; O Eichler; M Glas; H Urbach; Ulrich Herrlinger
Journal:  J Neurooncol       Date:  2010-06-09       Impact factor: 4.130

3.  Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings.

Authors:  Nobuyuki Kawai; Shuichi Okubo; Keisuke Miyake; Yukito Maeda; Yuka Yamamoto; Yoshihiro Nishiyama; Takashi Tamiya
Journal:  Ann Nucl Med       Date:  2010-04-09       Impact factor: 2.668

Review 4.  Glucocorticoid treatment of primary CNS lymphoma.

Authors:  M Weller
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 5.  Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.

Authors:  Kelvin K Yap; Tom Sutherland; Elaine Liew; Con J Tartaglia; Mei Pang; Nick Trost
Journal:  J Med Imaging Radiat Oncol       Date:  2012-03-06       Impact factor: 1.735

Review 6.  Primary CNS Lymphoma.

Authors:  Christian Grommes; Lisa M DeAngelis
Journal:  J Clin Oncol       Date:  2017-06-22       Impact factor: 44.544

7.  Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.

Authors:  Anouk van Westrhenen; Lisanne C A Smidt; Tatjana Seute; Stefan Nierkens; Abraham C J Stork; Monique C Minnema; Tom J Snijders
Journal:  Br J Haematol       Date:  2018-05-29       Impact factor: 6.998

8.  Utility of flouro-deoxy-glucose positron emission tomography/computed tomography in the diagnostic and staging evaluation of patients with primary CNS lymphoma.

Authors:  Meetakshi Gupta; Tejpal Gupta; Nilendu Purandare; Venkatesh Rangarajan; Ameya Puranik; Aliasgar Moiyadi; Prakash Shetty; Sridhar Epari; Ayushi Sahay; Abhishek Mahajan; Amit Janu; Bhausaheb Bagal; Hari Menon; Sadhana Kannan; Rahul Krishnatry; Goda Jayant Sastri; Rakesh Jalali
Journal:  CNS Oncol       Date:  2019-11-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.